The model suggested that, for interventions expanding HIV treatment only, without any change in testing rates, reductions in new diagnoses with evidence of acute HIV or early infection (CD4 >500cells/μl) reflected reductions in HIV incidence sufficiently well to envisage their use for estimating intervention impact on HIV incidence in a C-RCT. This evidence concerns the gene CD4 and infection.